logo
#

Latest news with #SixthStreetPartners

AM Best Affirms Credit Ratings of Cavello Bay Reinsurance Limited
AM Best Affirms Credit Ratings of Cavello Bay Reinsurance Limited

Yahoo

time22-07-2025

  • Business
  • Yahoo

AM Best Affirms Credit Ratings of Cavello Bay Reinsurance Limited

OLDWICK, N.J., July 22, 2025--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating of A (Excellent) and a Long-Term Issuer Credit Rating of "a+" (Excellent) of Cavello Bay Reinsurance Limited (Cavello Bay) (Bermuda), a subsidiary of Enstar Group Limited (Enstar) (Bermuda). The outlook of these Credit Ratings (ratings) is stable. The ratings reflect Cavello Bay's balance sheet strength, which AM Best assesses as very strong, as well as its strong operating performance, favorable business profile and appropriate enterprise risk management. The affirmation reflects a continuation of Enstar's robust capitalization through its acquisition by Sixth Street Partners, LLC (Sixth Street). In recent years, Enstar has established itself as a market leader in the non-life runoff space and continues to introduce new products to service short-tailed and insurance-linked securities solutions as well. AM Best anticipates that the business model will remain generally consistent under the ownership of Sixth Street. This press release relates to Credit Ratings that have been published on AM Best's website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best's Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings. For information on the proper use of Best's Credit Ratings, Best's Performance Assessments, Best's Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best's Ratings & Assessments. AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit Copyright © 2025 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED. View source version on Contacts Dan Hofmeister, CFA, FRM, CAIA, CPCU Associate Director +1 908 882 1893 Christopher Sharkey Associate Director, Public Relations +1 908 882 2310 Steven M. Chirico, CPA Director +1 908 882 1694 Al Slavin Senior Public Relations Specialist +1 908 882 2318

Sixth Street Sees Wins in Europe's Dysfunctional Capital Markets
Sixth Street Sees Wins in Europe's Dysfunctional Capital Markets

Bloomberg

time11-07-2025

  • Business
  • Bloomberg

Sixth Street Sees Wins in Europe's Dysfunctional Capital Markets

Sixth Street Partners is scaling up in London, betting that dysfunctional debt and equity capital markets across Europe will create more investment opportunities. Executives in Europe are increasingly avoiding the public markets or looking to sell their firms to US buyers for higher valuations, according to Julian Salisbury, partner and co-chief investment officer for Sixth Street. That presents opportunities to Sixth Street, which provides financing for European firms that are still private or in pursuing takeovers of already-listed firms, according to Salisbury.

Caris Life Sciences Shares Climb After $494 Million IPO
Caris Life Sciences Shares Climb After $494 Million IPO

Bloomberg

time18-06-2025

  • Business
  • Bloomberg

Caris Life Sciences Shares Climb After $494 Million IPO

By and Anthony Hughes Save Caris Life Sciences Inc. jumped as much as 40% after the health-care company raised $494 million in a US initial public offering that priced above the top of its marketed range. Shares of the Sixth Street Partners -backed firm, which uses technology to help diagnose and treat cancer, traded at $28.46 each at 12:35 p.m. on Wednesday in New York, versus an IPO price of $21 apiece. Caris sold 23.5 million shares after offering them for $19 to $20 each, in a range that had already been increased.

Caris Life Sciences IPO Prices Above Range to Raise $494 Million
Caris Life Sciences IPO Prices Above Range to Raise $494 Million

Bloomberg

time18-06-2025

  • Business
  • Bloomberg

Caris Life Sciences IPO Prices Above Range to Raise $494 Million

Caris Life Sciences Inc., a health-care company that uses technology to help diagnose and treat cancer, raised $494 million in a US initial public offering that priced above the top of its marketed range. The Sixth Street Partners -backed company sold 23.5 million shares at $21 each, according to a statement Tuesday. The medical technology firm had offered shares for $19 to $20 each, above a previous proposed range of $16 to $18, an earlier filing showed.

Medtech Caris Life Sciences Seeks to Raise $423.5 Million in IPO
Medtech Caris Life Sciences Seeks to Raise $423.5 Million in IPO

Bloomberg

time09-06-2025

  • Business
  • Bloomberg

Medtech Caris Life Sciences Seeks to Raise $423.5 Million in IPO

Caris Life Sciences Inc., a health-care company that uses technology to help diagnose and treat cancer, is seeking to raise $423.5 million in an initial public offering. The Sixth Street Partners -backed company plans to market 23.5 million shares for $16 to $18 each, according to its filing on Monday with the US Securities and Exchange Commission. Neuberger Berman indicated it would be interested in buying as much as $75 million of the offering at the IPO price, the filing shows.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store